CompletedPhase 4

Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine

South Korea77 participantsStarted 2020-02-24

Plain-language summary

The quality of recovery in patients who were reversed neuromuscular blockade by using Sumamadex and Neostigmine in laparoscopic cholecystectomy was compared through the QoR(Quality of Recovery)-15 questionnaire.

Who can participate

Age range20 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients who underwent laparoscopic cholecystectomy aged 20-70 Exclusion Criteria: * neuromuscular disease * allergy to rocuronium, sugammadex, neostigmine * cognitive impairment ( disable to answer the questionnaire ) * refuse to participate

What they're measuring

Quality of Recovery(QoR)-15 questionnaire score

Timeframe: preoperative 1 days to postoperative 2 days

Trial details

NCT IDNCT04332627

SponsorSeoul National University Bundang Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-05-21

View on ClinicalTrials.gov More Neuromuscular Blockade Reversal Agent trials